Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
101 studies found for:    Emphysema: Clinical Trials
Show Display Options
Rank Status Study
21 Not yet recruiting Bronchoscopic EmphysemA Treatment in THE NetherLands
Condition: COPD
Intervention:
22 Completed GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: fluticasone propionate/salmeterol combination DISKUS
23 Not yet recruiting Implementing and Evaluating the Genie Tool in COPD
Conditions: COPD;   Emphysema
Intervention: Behavioral: GENIE - social networking tool
24 Not yet recruiting Losartan Effects on Emphysema Progression
Condition: Emphysema
Interventions: Drug: Losartan;   Drug: Placebo
25 Not yet recruiting Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System
Condition: Emphysema
Intervention: Device: AeriSeal System
26 Completed
Has Results
A Randomized Trial of Internet Access to Nicotine Patches
Conditions: Smoking Cessation;   Tobacco Use Disorder
Interventions: Drug: Nicotine patches;   Behavioral: Telephone counseling;   Behavioral: iQuit Smoking website
27 Completed Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
Conditions: Emphysema;   Lung Diseases;   Lung Diseases, Obstructive;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: all trans retinoic acid;   Drug: 13 cis retinoic acid;   Drug: placebo
28 Completed Very Early Surfactant and NCPAP for Premature Infants With RDS
Conditions: Respiratory Distress Syndrome;   Pneumothorax/Pulmonary Intersticial Emphysema;   Chronic Lung Disease
Interventions: Other: Very early surfactant and bubble NCPAP;   Other: bubble NCPAP
29 Completed Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema
Condition: Pulmonary Emphysema
Intervention: Other: Blood sampling
30 Completed A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants
Condition: Respiratory Distress Syndrome
Interventions: Drug: Butantan;   Drug: Control
31 Completed Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol combination DISKUS;   Drug: salmeterol xinafoate
32 Completed Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Relaxation Response (instruction, pocket practice card prov);   Behavioral: Mindfulness training using model developed from UMass
33 Recruiting Doxycycline for COPD in HIV-Infected Patients
Conditions: HIV;   Chronic Obstructive Pulmonary Disease (COPD);   Emphysema
Interventions: Drug: Doxycycline;   Drug: Placebo (sugar pill)
34 Unknown  Sequential Endoscopic Lung Volume Reduction
Conditions: Emphysema;   COPD
Intervention: Device: Zephyr endobronchial valve
35 Unknown  Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   Inflammation;   Pulmonary Emphysema
Interventions: Drug: Doxycycline;   Drug: Placebo
36 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS 250/50 mg BID;   Drug: SEREVENT 50 mcg BID
37 Not yet recruiting Acute Dyspnea After Use of Non-invasive Ventilation in COPD and Emphysema (Deventilation Syndrome)
Condition: Obstructive Chronic Bronchitis
Intervention:
38 Unknown  Endobronchial Valves in Moderate COPD
Condition: Moderate COPD
Intervention: Device: Zephyr endobronchial valve placement
39 Recruiting Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for Emphysema
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Device: RePneu Lung Volume Reduction Coil System
40 Enrolling by invitation An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Intervention: Drug: Inhaled Treprostinil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.